Mood Disorders News

Findings from a network meta-analysis indicated that out of 14 antidepressant treatments, only fluoxetine had some efficacy for treatment of major depression in youth.

Researchers found that selective serotonin reuptake inhibitors were associated with a risk of Apgar scores less than 7, according to data presented at the Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists.

ATLANTA — Inclusion and exclusion criteria for antidepressant efficacy studies may weaken the application of study findings to clinical practice, according to Mark Zimmerman, MD, of director of outpatient psychiatry at Rhode Island Hospital.

Trintellix, a once-daily oral antidepressant indicated for major depression in adults, is now available in U.S. pharmacies, according to a press release from Takeda Pharmaceuticals and Lundbeck.

The rate of postpartum readmissions increased nearly 0.5% during the course of 7 years, according to data presented at the Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists.

ATLANTA — David Mischoulon, MD, PhD, of Massachusetts General Hospital, discusses an upcoming study assessing vitamin D and omega-3 fatty acids for the prevention of depression and improvement of mood in older adults.

ATLANTA — Susan Samuels, MD, child and adolescent psychiatrist at New York-Presbyterian and Weill Cornell Medicine, emphasizes the burden of psychiatric comorbidities of chronic illness and how clinicians can manage them in adolescents.

ATLANTA — Adjunctive Latuda was associated with significantly improved time to recurrence of mood or depressive episode among individuals with bipolar I disorder and stable response to acute treatment, according to data presented here.

ATLANTA — Depression-related hospitalizations have steadily increased in the United States and significant racial/ethnic disparities in utilization of mental health care exist, according to data presented at the American Psychiatric Association Annual Meeting.

ATLANTA — NeuroStar transcranial magnetic stimulation showed efficacy as monotherapy for treatment of postpartum-onset major depressive disorder in women, according to data presented at the American Psychiatric Association Annual Meeting.